Study to Evaluate the inHaled Recombinant COVID-19 Vaccine (Adenovirus Type 5 Vector) On the Protective-Efficacy in Adults (SeiHOPE)
Clinical trial NCT05124561 · WITHDRAWN
Trial details
- NCT number
- NCT05124561
- Sponsor
- CanSino Biologics Inc.
- Status
- WITHDRAWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-15
- Primary completion
- 2022-04-15
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.